Skip to content
Arcus Biosciences Inc icon

Arcus Biosciences Inc

RCUSStocksBiotechnologyUnited StatesNYSEUSD

Price

$24.24

Today

-1.9%

YTD

+2.4%

About

Arcus Biosciences, Inc. is an American pharmaceutical company dedicated to creating cancer therapies. Its operations include the discovery, development, and commercialisation of new treatments for oncology patients. Arcus Biosciences operates in the pharmaceutical industry, specifically focusing on oncology therapeutics. The company has developed multiple prescription medicines aimed at cancer treatment, both standalone and in combination with other drugs. While an individual entity, Arcus has initiated key collaborations with other leaders in the pharmaceutical industry to further its pharmaceutical developments. Explore the potential of RCUS by adding it to your eToro watchlist.

Price chart
Closing price history for RCUS (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-6.34
P/S (TTM)26.66
P/B (TTM)6.77
Market cap$3.15B
Cap tierMid-cap
Industry avg P/E-1.91

Profitability

Gross margin92.31%
EBIT margin-415.38%
Net margin-221.95%
ROE-90.82%
ROA-46.02%

Earnings & Revenue

Revenue (TTM)$117.00M
Revenue growth (1Y)-55.3%
EPS (TTM)-$3.90
Free cash flow$-475.00M
Total debt$114.00M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.58
Employees601
Next earnings27 Oct '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Arcus Biosciences Inc (RCUS) | Dirk Kuyken